These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21620515)

  • 1. A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine-derived membrane material in patients with venous leg ulcers.
    Kelechi TJ; Mueller M; Hankin CS; Bronstone A; Samies J; Bonham PA
    J Am Acad Dermatol; 2012 Jun; 66(6):e209-15. PubMed ID: 21620515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of two refractory venous stasis ulcers treated with a novel poly-N-acetyl glucosamine-derived membrane.
    Maus EA
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22778460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost efficacy of advanced wound care matrices for venous ulcers.
    Hankin CS; Knispel J; Lopes M; Bronstone A; Maus E
    J Manag Care Pharm; 2012 Jun; 18(5):375-84. PubMed ID: 22663170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse.
    Pietramaggiori G; Yang HJ; Scherer SS; Kaipainen A; Chan RK; Alperovich M; Newalder J; Demcheva M; Vournakis JN; Valeri CR; Hechtman HB; Orgill DP
    J Trauma; 2008 Mar; 64(3):803-8. PubMed ID: 18332827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the freeze-dried cultured human keratinocyte lysate, LyphoDerm 0.9%, in the treatment of hard-to-heal venous leg ulcers.
    Harding KG; Krieg T; Eming SA; Flour ML; Jawien A; Cencora A; Kaszuba A; Noszcyk W; Willems P; De Deene A; Joos E; De Waele P; Delaey B
    Wound Repair Regen; 2005; 13(2):138-47. PubMed ID: 15828938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
    Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
    Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers.
    Meaume S; Truchetet F; Cambazard F; Lok C; Debure C; Dalac S; Lazareth I; Sigal ML; Sauvadet A; Bohbot S; Dompmartin A;
    Wound Repair Regen; 2012; 20(4):500-11. PubMed ID: 22681551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
    Landsman AS; Cook J; Cook E; Landsman AR; Garrett P; Yoon J; Kirkwood A; Desman E
    Foot Ankle Spec; 2011 Feb; 4(1):29-41. PubMed ID: 21135263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers.
    Vowden P; Romanelli M; Peter R; Boström A; Josefsson A; Stege H
    Wound Repair Regen; 2006; 14(3):240-6. PubMed ID: 16808801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study.
    Schumann H; Calow T; Weckesser S; Müller ML; Hoffmann G
    Br J Dermatol; 2011 Sep; 165(3):541-51. PubMed ID: 21574975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial healing rates of venous ulcers: are they useful as predictors of healing?
    Hill DP; Poore S; Wilson J; Robson MC; Cherry GW
    Am J Surg; 2004 Jul; 188(1A Suppl):22-5. PubMed ID: 15223498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers: a randomized, controlled, multicenter study.
    Beckert S; Warnecke J; Zelenkova H; Kovnerystyy O; Stege H; Cholcha W; Königsrainer A; Coerper S
    J Vasc Surg; 2006 Jan; 43(1):94-100. PubMed ID: 16414395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial rate of healing predicts complete healing of venous ulcers.
    Tallman P; Muscare E; Carson P; Eaglstein WH; Falanga V
    Arch Dermatol; 1997 Oct; 133(10):1231-4. PubMed ID: 9382561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, controlled trial comparing the effects of noncontact, low-frequency ultrasound to standard care in healing venous leg ulcers.
    Gibbons GW; Orgill DP; Serena TE; Novoung A; O'Connell JB; Li WW; Driver VR
    Ostomy Wound Manage; 2015 Jan; 61(1):16-29. PubMed ID: 25581604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of chronic venous ulcers with sucralfate: a placebo controlled randomized study.
    Tumino G; Masuelli L; Bei R; Simonelli L; Santoro A; Francipane S
    Int J Mol Med; 2008 Jul; 22(1):17-23. PubMed ID: 18575771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.
    Coccheri S; Scondotto G; Agnelli G; Aloisi D; Palazzini E; Zamboni V;
    Thromb Haemost; 2002 Jun; 87(6):947-52. PubMed ID: 12083500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More frequent visits to wound care clinics result in faster times to close diabetic foot and venous leg ulcers.
    Warriner RA; Wilcox JR; Carter MJ; Stewart DG
    Adv Skin Wound Care; 2012 Nov; 25(11):494-501. PubMed ID: 23080236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline--efficient in the treatment of venous ulcers in the absence of compression?
    Nikolovska S; Pavlova L; Petrova N; Gocev G; Ivanovski M
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):9-13. PubMed ID: 12137725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial.
    Kiesewetter H; Koscielny J; Kalus U; Vix JM; Peil H; Petrini O; van Toor BS; de Mey C
    Arzneimittelforschung; 2000 Feb; 50(2):109-17. PubMed ID: 10719612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.